The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT
Recruiting
Observational Study
Cardiovascular Risk
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Male
- Study type
- Observational
- Participants needed
- 130 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prostate cancer is characterised by its slow progression nature, and even for metastatic disease, the 5-year survival is up to 30%. While ADT can effectively control disease, there is increasing evidence suggesting that it can also result in many adverse cardiovascular side effects on the patients, and these effects are particularly important due to the prolonged survival of these patients. There …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult men 18-80 years old
* With histological proven prostate cancer or clinically diagnosed to have prostate cancer,
* Planned for ADT for at least 1 year
Exclusion Criteria:
* Subjects with established major atherosclerotic cardiovascular disease (ASCVD) as defined by a re…
Contacts